Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04484220 · ClinicalTrials.gov registry record · NA
Ellipsys Vascular Access System Post Market Surveillance (PS) Study
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT04484220 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 142 participants.
The verdict
NCT04484220, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.
Interventions
- DEVICE Ellipsys Vascular Access System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2021-04-13 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04484220
The ClinicalTrials.gov registry entry for NCT04484220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ellipsys Vascular Access System is the first listed.
NCT04484220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04484220 about?
NCT04484220 is a clinical study titled "Ellipsys Vascular Access System Post Market Surveillance (PS) Study". The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.
What is the current status of trial NCT04484220?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2021-04-13. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04484220?
The interventions under investigation include: Ellipsys Vascular Access System (DEVICE).
Who is sponsoring clinical trial NCT04484220?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.